Plague Vaccine - Centers for Disease Control and Prevention
Because human plague is rare in most parts of the world, there is no need to vaccinate persons other than those at particularly high risk of exposure. Routine vaccination is not necessary for persons living in areas with enzootic plague such as the western United States.
Plague vaccine - Wikipedia
A plague vaccine is used for an induction of active specific immunity in an organism susceptible to plague by means of administrating an antigenic material (a vaccine) via a variety of routes to people at risk of contracting any clinical form of plague. This …
Plague vaccine: recent progress and prospects - PMC - PubMed …
In this review, we summarize the latest advances in research and development of plague vaccines. Plague is caused by the facultative, intracellular Gram-negative bacterial pathogen, Yersinia pestis.
Plague vaccine: recent progress and prospects | npj Vaccines
2019年2月18日 · In this review, we summarize the latest advances in research and development of plague vaccines. Plague is caused by the facultative, intracellular Gram-negative bacterial pathogen, Yersinia...
Plague Vaccine Development: Current Research and Future Trends
EV NIIEG is the only approved vaccine against plague for human use during plague outbreaks. The short-term immunity and the concern of safety are the limitations of this vaccine. Additionally, LPV provides poor protection to mice against non-encapsulated Y. pestis challenge ( 25 ).
Preventing Plague | Plague | CDC - Centers for Disease Control …
2024年5月15日 · Note: A plague vaccine is no longer available in the United States. New plague vaccines are in development but are not expected to be commercially available in the immediate future. Kettles, buckets, lanterns, and other equipment were used in catching rats during the Public Health Service campaign against the New Orleans...
Prevention of Plague: Recommendations of the Advisory Committee …
Plague vaccine should not be administered to persons who have a history of hypersensitivity to the vaccine or its components. Persons who have an acute febrile illness (e.g., influenza) should not be vaccinated until they have recovered fully.
The efficacy, safety, and immunogenicity of plague vaccines: A ...
Abstract. Plague remains endemic in many parts of the world, and despite efforts, no preventative vaccine is available. We performed a systemic review of available randomised controlled trials (RCTs) of live, attenuated, or killed plague vaccines vs. placebo, no intervention, or other plague vaccine to evaluate their efficacy, safety, and immunogenicity.
The efficacy, safety, and immunogenicity of plague vaccines: A
2023年11月1日 · We performed a systemic review of available randomised controlled trials (RCTs) of live, attenuated, or killed plague vaccines vs. placebo, no intervention, or other plague vaccine to evaluate their efficacy, safety, and immunogenicity.
Plague Vaccine - an overview | ScienceDirect Topics
Current plague vaccines have not been proven to be an approach that can effectively prevent plague outbreaks. Vaccination is of little use during human plague outbreaks, since a month or more is required to develop a protective immune response. Plague …